Porto poster: alemtuzumab improves disability

#MSBlog: Alemtuzumab increases your chances of sustained or confirmed disability improvement compared to interferon-beta.

“Apologies for putting this poster up so late; it is from the Neuroimmunology Meeting in Porto a few weeks ago. I simply forgot. Its subject matter is self-explanatory!”

CoI: multiple

About the author

Prof G

Professor of Neurology, Barts & The London. MS & Preventive Neurology thinker, blogger, runner, vegetable gardener, husband, father, cook and wine & food lover.

1 comment

By Prof G



Recent Posts

Recent Comments